Omixon is a global transplantation diagnostic company with a mission to provide histocompatibility laboratories with innovative technologies to improve transplant outcomes. Omixon is headquartered in Budapest, Hungary, with operations in the United States, Brazil and the Netherlands serving more than 100 laboratories worldwide.
Building on multidisciplinary competences in bioinformatics, software engineering, molecular biology and regulatory science, Omixon transforms molecular biology innovations into state-of-the-art products in transplant diagnostics.
Omixon was the first to successfully introduce NGS-based HLA typing kit and software in 2014 by bringing Holotype HLA, an NGS-based HLA genotyping product, and HLA Twin software to market. Omixon Twin delivers the most accurate high-resolution HLA genotyping and is used in more than 100+ laboratories worldwide.
Omixon was the first to release a high-resolution HLA genotyping product NanoTYPE HLA™ with less than 5 hours turnaround time on the Oxford Nanopore sequencing platform complemented by NanoTYPER™ analysis software.
Omixon is the first to bring to market the first donor-derived cell-free DNA kit HoloGRAFT for laboratories with donor-informative genetic markers with primer and probe sequences that are absent in the patient genotype by design.
On October 16, 2024, in Barcelona, Spain, Werfen announced the completion of its acquisition of Omixon, after securing all required regulatory and antitrust approvals.
Company Details
- Employees
- 54
- Founded
- -
- Address
- Kaposvár St 14-18., Ground And 1st Floor,united States
- Phone
- (617) 500 0790
- sa****@****xon.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- omixon.com
- Keywords
- data analysis, next-generation sequencing, software development, NGS, HLA typing, HLA Assay and Software, Whole Gene Sequencing, Whole Exome Sequencing, HLA Genotyping kit, Omixon Academy, automation, epitope matching, molecular diagnostics, nanopore technology, ddcfDNA monitoring, qPCR, dPCR.
- HQ
- Budapest
Omixon Questions
Omixon's helpline number is (617) 500 0790
Omixon's website is omixon.com
Omixon's LinkedIn profile is https://www.linkedin.com/company/omixon
Omixon has
54 employees.
View email and phone details for 54
employees at Omixon.
Omixon's industry is
Biotechnology Research
Omixon's top competitors are
Oxford Nanopore Technologies,
Richter Gedeon Nyrt. / Magyarország,
Vrg Therapeutics,
Caredx, Inc.,
Turbine,
Biotalentum Ltd.,
Immucor, Inc.,
Werfen,
Eurobio Scientific Fr,
Gendx.
Omixon's support email address is sales@omixon.com
Omixon's categories are Biotechnology Research
Omixon's founding year is 2011
